Eargo 8 vs Resound Vivia 9 60S microRIE

The Eargo 8 is a premium-priced OTC hearing aid ($2,399) that earns a B grade with a SoundScore of 3.3/5 in our lab testing. This invisible-in-ear device represents Eargo's 2025 flagship offering, featuring a rechargeable design that sits completely within the ear canal. In our testing, the Eargo 8 showed mixed performance across key metrics. Speech clarity in quiet environments is a relative strength, scoring 0.27 points above the OTC category average. Own-voice comfort also performs well, measuring 0.69 points above average at 3.2/5—a solid result that suggests reduced occlusion effects during conversation. However, speech understanding in noisy environments scored 1.2/5, which is both low in absolute terms and 0.27 points below the category average. The most significant limitation we measured was music streaming, which scored 0.0/5—nearly 2 points below the OTC average. This makes the Eargo 8 unsuitable for users who prioritize streaming audio quality. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average. At its premium price point, the Eargo 8 faces stiff competition. Several devices in our database deliver comparable or better sound performance at lower prices, including alternatives from Eargo's own lineup. The Eargo 8 is best suited for users who prioritize invisible cosmetics and own-voice comfort over streaming capability and value, and who primarily need help hearing speech in quieter settings.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.